Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment

Journal of Neurotrauma

Volumn 24, Issue 11, 2007, Pages 1743-1759

  Iaci, Jennifer F ^a   Vecchione, Andrea M ^a   Zimber, Michael P ^a   Caggiano, Anthony O ^a  

^a ACORDA THERAPEUTICS INC   (United States)

Author keywords

Extracellular matrix; Models of injury; Neuroplasticity; Regeneration; Traumatic spinal cord injury

Indexed keywords

N ACETYLGALACTOSAMINE 4 SULFATASE; NEUROCAN; PHOSPHACAN; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONTUSION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEMALE; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN CONTENT; RAT; REAL TIME POLYMERASE CHAIN REACTION; SENSORIMOTOR FUNCTION; SPINAL CORD INJURY; WESTERN BLOTTING;

ANIMALS; CHONDROITIN ABC LYASE; CONTUSIONS; FEMALE; PROTEOCHONDROITIN SULFATES; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD INJURIES; THORACIC VERTEBRAE; TIME FACTORS;

EID: 39449134309     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2007.0366     Document Type: Article

References (69)

1. ASHER, R.A., MORGENSTERN, D.A., FIDLER, P.S., ADCOCK, K.H., OOHIRA, A., BRAISTEAD, J.E., LEVINE, J.M., MARGOLIS, R.U., ROGERS, J.H., and FAWCETT, J.W. (2000). Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 20, 2427-2438.
2. ASHER, R.A., MORGENSTERN, D.A., MOON, L.D., and FAWCETT, J.W. (2001). Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog. Brain Res. 132, 611-619.
3. ASHER, R.A., MORGENSTERN, D.A., SHEARER, M.C., ADCOCK, K.H., PESHEVA, P., and FAWCETT, J.W. (2002). Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J. Neurosci. 22, 2225-2236.
4. BANDTLOW, C.E., and ZIMMERMANN, D.R. (2000) Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 80, 1267-1290.
5. BARRITT, A.W., DAVIES, M., MARCHAND, F., HARTLEY, R., GRIST, J., YIP, P., MCMAHON, S.B., and BRADBURY, E.J. (2006). Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 26, 10856-10867.
6. BRADBURY, E.J., MOON, L.D., POPAT, R.J., KING, V.R., BENNETT, G.S., PATEL, P.N., FAWCETT, J.W., and MCMAHON, S.B. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640.
7. BRITTIS, P.A., and SILVER, J. (1995). Multiple factors govern intraretinal axon guidance: a time-lapse study. Mol. Cell Neurosci. 6, 413-432.
8. BRUCE, J.H., NORENBERG, M.D., KRAYDIEH, S., PUCKETT, W., MARCILLO, A., and DIETRICH, D. (2000). Schwannosis: role of gliosis and proteoglycan in human spinal cord injury. J. Neurotrauma 17, 781-788.
9. BRUCKNER, G., BRINGMANN, A., HARTIG, W., KOPPE, G., DELPECH, B., and BRAUER, K. (1998). Acute and long-lasting changes in extracellular-matrix chondroitin-sulphate proteoglycans induced by injection of chondroitinase ABC in the adult rat brain. Exp. Brain Res. 121, 300-310.
10. BUKALO, O., SCHACHNER, M., and DITYATEV, A. (2001). Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 104, 359-369.
11. BUNGE, R.P., PUCKETT, W.R., and HIESTER, E.D. (1997). Observations on the pathology of several types of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries. Adv. Neurol. 72, 305-315.
12. BUSS, A., BROOK, G.A., KAKULAS, B., MARTIN, D., FRANZEN, R., SCHOENEN, J., NOTH, J., and SCHMITT, A.B. (2004). Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 127, 34-44.
13. CAFFERTY, W.B., YANG, S.H., DUFFY, P.J., LI, S., and STRITTMATTER, S.M. (2007). Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J. Neurosci. 27, 2176-2185.
14. CAGGIANO, A.O., ZIMBER, M.P., GANGULY, A., BLIGHT, A.R., and GRUSKIN, E.A. (2005). Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J. Neurotrauma 22, 226-239.
15. CARBONETTO, S., GRUVER, M.M., and TURNER, D.C. (1983). Nerve fiber growth in culture on fibronectin, collagen, and glycosaminoglycan substrates. J. Neurosci. 3, 2324-2335.
16. CARMICHAEL, S.T., ARCHIBEQUE, I., LUKE, L., NOLAN, T., MOMIY, J., and LI, S. (2005). Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp. Neurol. 193, 291-311.
17. CATERSON, B., CHRISTNER, J.E., BAKER, J.R., and COUCHMAN, J.R. (1985). Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed. Proc. 44, 386-393.
18. CHAU, C.H., SHUM, D.K., LI, H., PEI, J., LUI, Y.Y., WIRTHLIN, L., CHAN, Y.S., and XU, X.M. (2004). Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J. 18, 194-196.
19. CHEN, Z.J., UGHRIN, Y., and LEVINE, J.M. (2002). Inhibition of axon growth by oligodendrocyte precursor cells. Mol. Cell Neurosci. 20, 125-139.
20. CORVETTI, L., and ROSSI, F. (2005). Degradation of chondroitin sulfate proteoglycans induces sprouting of intact purkinje axons in the cerebellum of the adult rat. J. Neurosci. 25, 7150-7158.
21. DERGHAM, P., ELLEZAM, B., ESSAGIAN, C., AVEDISSIAN, H., LUBELL, W.D., and MCKERRACHER, L. (2002). Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570-6577.
22. DOMENICONI, M., and FILBIN, M.T. (2005). Overcoming inhibitors in myelin to promote axonal regeneration. J. Neurol. Sci. 233, 43-47.
23. DOU, C.L., and LEVINE, J.M. (1994). Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14, 7616-7628.
24. FOUAD, K., SCHNELL, L., BUNGE, M.B., SCHWAB, M.E., LIEBSCHER, T., and PEARSE, D.D. (2005). Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 25, 1169-1178.
25. FOURNIER, A.E., GOULD, G.C., LIU, B.P., and STRITTMATTER, S.M. (2002). Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J. Neurosci. 22, 8876-8883.
26. GOLGI, C. (1893). Intorno all'origine del quarto nervo cerebrale e una questione istofisiologica che a questo argomento si collega. Rendiconti della Reale Accademia Del Lincei 433-450.
27. GRIMPE, B., and SILVER, J. (2004). A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J. Neurosci. 24, 1393-1397.
28. GRIS, P., TIGHE, A., LEVIN, D., SHARMA, R., and BROWN, A. (2007). Transcriptional regulation of scar gene expression in primary astrocytes. Glia 55, 1145-1155.
29. GRUNER, J.A., YEE, A.K., and BLIGHT, A.R. (1996). Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res. 729, 90-101.
30. HALL, E.D. (2001). Pharmacological treatment of acute spinal cord injury: how do we build on past success? J. Spinal Cord Med. 24, 142-146.
31. HAYES, K.C., and KAKULAS, B.A. (1997). Neuropathology of human spinal cord injury sustained in sports-related activities. J. Neurotrauma 14, 235-248.
32. HOKE, A., and SILVER, J. (1996). Proteoglycans and other repulsive molecules in glial boundaries during development and regeneration of the nervous system. Prog. Brain Res. 108, 149-163.
33. HOULE, J.D., TOM, V.J., MAYES, D., WAGONER, G., PHILLIPS, N., and SILVER, J. (2006). Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J. Neurosci. 26, 7405-7415.
34. HUANG, W.C., KUO, W.C., CHERNG, J.H., HSU, S.H., CHEN, P.R., HUANG, S.H., HUANG, M.C., LIU, J.C., and CHENG, H. (2006). Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem. Biophys. Res. Commun. 349, 963-968.
35. JONES, L.L., MARGOLIS, R.U., and TUSZYNSKI, M.H. (2003). The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 182, 399-411.
36. JONES, L.L., YAMAGUCHI, Y., STALLCUP, W.B., and TUSZYNSKI, M.H. (2002). NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22, 2792-2803.
37. KIM, B.G., DAI, H.N., LYNSKEY, J.V., MCATEE, M., and BREGMAN, B.S. (2006). Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats. J. Comp. Neurol. 497, 182-198.
38. KJELLEN, L., and LINDAHL, U. (1991). Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60, 443-475.
39. LANDER, C., KIND, P., MALESKI, M., and HOCKFIELD, S. (1997). A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J. Neurosci. 17, 1928-1939.
40. LANDER, C., ZHANG, H., and HOCKFIELD, S. (1998). Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J. Neurosci. 18, 174-183.
41. LEMONS, M.L., HOWLAND, D.R., and ANDERSON, D.K. (1999). Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp. Neurol. 160, 51-65.
42. LEMONS, M.L., SANDY, J.D., ANDERSON, D.K., and HOWLAND, D.R. (2003). Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord. Exp. Neurol. 184, 981-990.
43. LI, S., and CARMICHAEL, S.T. (2006). Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke. Neurobiol. Dis. 23, 362-373.
44. LI, S., LIU, B.P., BUDEL, S., LI, M., JI, B., WALUS, L., LI, W., JIRIK, A., RABACCHI, S., CHOI, E., WORLEY, D., SAH, D.W., PEPINSKY, B., LEE, D., RELTON, J., and STRITTMATTER, S.M. (2004). Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci. 24, 10511-10520.
45. MASSEY, J.M., HUBSCHER, C.H., WAGONER, M.R., DECKER, J.A., AMPS, J., SILVER, J., and ONIFER, S.M. (2006). Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J. Neurosci. 26, 4406-4414.
46. METZ, G.A., CURT, A., VAN DE MEENT, H., KLUSMAN, I., SCHWAB, M.E., and DIETZ, V. (2000). Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. J. Neurotrauma 17, 1-17.
47. MORGENSTERN, D.A., ASHER, R.A., and FAWCETT, J.W. (2002). Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137, 313-332.
48. MURAKAMI, T., and OHTSUKA, A. (2003). Perisynaptic barrier of proteoglycans in the mature brain and spinal cord. Arch. Histol. Cytol. 66, 195-207.
49. PIZZORUSSO, T., MEDINI, P., BERARDI, N., CHIERZI, S., FAWCETT, J.W., and MAFFEI, L. (2002). Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298, 1248-1251.
50. PIZZORUSSO, T., MEDINI, P., LANDI, S., BALDINI, S., BERARDI, N., and MAFFEI, L. (2006). Structural and functional recovery from early monocular deprivation in adult rats. Proc. Natl. Acad. Sci. USA 103, 8517-8522.
51. PROPERZI, F., CARULLI, D., ASHER, R.A., MUIR, E., CAMARGO, L.M., VAN KUPPEVELT, T.H., TEN DAM, G.B., FURUKAWA, Y., MIKAMI, T., SUGAHARA, K., TOIDA, T., GELLER, H.M., and FAWCETT, J.W. (2005). Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur. J. Neurosci. 21, 378-390.
52. RAMON, S., DOMINGUEZ, R., RAMIREZ, L., PARAIRA, M., OLONA, M., CASTELLO, T., and GARCIA FERNANDEZ, L. (1997). Clinical and magnetic resonance imaging correlation in acute spinal cord injury. Spinal Cord 35, 664-673.
53. RAUCH, U., ZHOU, X.H., and ROOS, G. (2005). Extracellular matrix alterations in brains lacking four of its components. Biochem. Biophys. Res. Commun. 328, 608-617.
54. RHODES, K.E., and FAWCETT, J.W. (2004). Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? J. Anat. 204, 33-48.
55. SCHNELL, L., and SCHWAB, M.E. (1990). Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343, 269-272.
56. SILVER, J., and MILLER, J.H. (2004). Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156.
57. SNOW, D.M., LEMMON, V., CARRINO, D.A., CAPLAN, A.I., and SILVER, J. (1990a). Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109, 111-130.
58. SNOW, D.M., STEINDLER, D.A., and SILVER, J. (1990b). Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier. Dev. Biol. 138, 359-376.
59. SNOW, D.M., MULLINS, N., and HYNDS, D.L. (2001). Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. Microsc. Res. Tech. 54, 273-286.
60. SPICER, A.P., JOO, A., and BOWLING, R.A., JR. (2003). A hyaluronan binding link protein gene family whose members are physically linked adjacent to chondroitin sulfate proteoglycan core protein genes: the missing links. J. Biol. Chem. 278, 21083-21091.
61. STEINDLER, D.A. (1993). Glial boundaries in the developing nervous system. Annu. Rev. Neurosci. 16, 445-470.
62. SUZUKI, S., SAITO, H., YAMAGATA, T., ANNO, K., SENO, N., KAWAI, Y., and FURUHASHI, T. (1968). Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J. Biol. Chem. 243, 1543-1550.
63. TAKAHASHI-IWANAGA, H., MURAKAMI, T., and ABE, K. (1998). Three-dimensional microanatomy of perineuronal proteoglycan nets enveloping motor neurons in the rat spinal cord. J. Neurocytol. 27, 817-827.
64. TAN, A.M., ZHANG, W., and LEVINE, J.M. (2005). NG2: a component of the glial scar that inhibits axon growth. J. Anat. 207, 717-725.
65. TANG, X., DAVIES, J.E., and DAVIES, S.J. (2003). Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 71, 427-444.
66. THON, N., HAAS, C.A., RAUCH, U., MERTEN, T., FASSLER, R., FROTSCHER, M., and DELLER, T. (2000). The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur. J. Neurosci. 12, 2547-2558.
67. TROPEA, D., CALEO, M., and MAFFEI, L. (2003). Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. J. Neurosci. 23, 7034-7044.
68. YOUNG, W. (2002). Spinal cord contusion models. Prog. Brain Res. 137, 231-255.
69. ZHANG, S.X., GEDDES, J.W., OWENS, J.L., and HOLMBERG, E.G. (2005). X-irradiation reduces lesion scarring at the contusion site of adult rat spinal cord. Histol. Histopathol. 20, 519-530.